HealthEquity Reports Second Quarter Ended July 31, 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Oppenheimer Remains Bullish on HealthEquity (HQY) Following Solid 2Q
September 6, 2017 9:44 AM EDTOppenheimer reiterated an Outperform rating and $61.00 price target on HealthEquity, Inc (NASDAQ: HQY) following the company's 2Q earnings report. Revenues of $56.9M beat estimates of $55.8M and adjusted EPS of $0.27 beat estimates of $0.18, mainly on tax benefits.
HQY raised its FY18... More
HealthEquity (HQY) Tops Q2 EPS by 12c, Sales Rise 29%; Raises Outlook
September 5, 2017 4:09 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.27, $0.12 better than the analyst estimate of $0.15. Revenue for the quarter came in at $56.9 million versus the consensus estimate of $55.66 million.
Revenue of $56.9 million, an increase of 29% compared to Q2 FY17.Net income of $16.9 million, an increase of 106% compared to Q2 FY17.Net income per diluted share of $0.27 compared to $0.14 in Q2 FY17.Adjusted EBITDA of $23.9 million, an increase of 30% compared to Q2... More